Biofarm S.A., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and has established a significant presence across various operational regions. Founded in 1991, the company has achieved notable milestones, including the expansion of its product portfolio and the enhancement of its manufacturing capabilities. Specialising in the development and production of high-quality generic medicines, Biofarm S.A. is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of pharmaceuticals, particularly in the fields of cardiology, dermatology, and gynaecology, setting it apart with its rigorous adherence to international standards. With a strong market position, Biofarm S.A. has garnered numerous accolades for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
How does Biofarm S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biofarm S.A.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biofarm S.A., headquartered in Romania (RO), currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established specific reduction targets or climate pledges, indicating a lack of formal commitments to address carbon emissions at this time. As there is no inherited emissions data from a parent company or related organization, Biofarm S.A. operates independently regarding its climate impact reporting. The absence of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is increasingly important for companies to adopt measurable climate commitments and reduction targets to align with global sustainability goals. Biofarm S.A. may benefit from exploring industry-standard frameworks such as the Science Based Targets initiative (SBTi) to enhance its climate action efforts in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biofarm S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.